MASI - Masimo Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
169.74
-0.09 (-0.05%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close169.83
Open170.29
Bid161.00 x 900
Ask175.50 x 800
Day's Range168.49 - 170.78
52 Week Range117.19 - 170.78
Volume249,081
Avg. Volume303,625
Market Cap9.1B
Beta (5Y Monthly)1.13
PE Ratio (TTM)50.82
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 21, 2012
1y Target EstN/A
  • Why Paycom Stock Leads 4 Long-Term Winners For Your Portfolio
    Investor's Business Daily

    Why Paycom Stock Leads 4 Long-Term Winners For Your Portfolio

    Cloud computing play Paycom stock leads four top stocks to consider for the long-term. Fiserv stock, UNH stock and Masimo stock also make the list. Here's why.

  • 4 High-Quality Health Care Companies for 2020
    GuruFocus.com

    4 High-Quality Health Care Companies for 2020

    Stocks to consider as China agrees to purchase $200 billion in US goods, including pharma Continue reading...

  • Masimo Posts Solid Preliminary 2019 Results, Issues Guidance
    Zacks

    Masimo Posts Solid Preliminary 2019 Results, Issues Guidance

    Higher revenues and upbeat 2020 outlook benefit Masimo's (MASI) preliminary full-year 2019 results.

  • Do You Know What Masimo Corporation's (NASDAQ:MASI) P/E Ratio Means?
    Simply Wall St.

    Do You Know What Masimo Corporation's (NASDAQ:MASI) P/E Ratio Means?

    Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll look at Masimo...

  • Masimo Corporation (MASI) vs. Top 20 Hedge Fund Stocks in 2019
    Insider Monkey

    Masimo Corporation (MASI) vs. Top 20 Hedge Fund Stocks in 2019

    Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged in 2019. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 57%. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted returns. That's why we weren't […]

  • Apple Stole Tech for Watch, Masimo Claims in Patent Suit
    Bloomberg

    Apple Stole Tech for Watch, Masimo Claims in Patent Suit

    (Bloomberg) -- Apple Inc. is accused of stealing trade secrets and improperly using Masimo Corp. inventions related to health monitoring in its Apple Watch.Masimo, which develops signal processing technology for health-care monitors, and its spinoff, Cercacor Laboratories Inc., claim in a lawsuit that Apple got secret information under the guise of a working relationship and then hired away key employees, including Michael O’Reilly, who became vice president of Apple’s health technology efforts.The business segment that includes the Apple Watch, Apple TV and Beats headphones is the company’s fastest-growing category and generated more than $24 billion in sales in the fiscal year that ended in September.Masimo and Cercacor said their technology for non-invasive monitoring using light was key to Apple overcoming performance issues with its Watch. Among the 10 patents Apple is accused of infringing are ones covering ways to measure oxygen levels in blood, and heart rate using light emitters and detectors.The companies are seeking orders that would block further use of their patented inventions in the Apple Watch 4 and 5, return of confidential information and unspecified damages.Officials with Cupertino, California-based Apple didn’t immediately return queries seeking comment.Apple contacted Masimo in 2013 and asked to meet for a potential collaboration, according to the complaint filed in federal court in Santa Ana, California. Apple said it wanted “to understand more about Masimo’s technology to potentially integrate that technology into Apple’s products,” Masimo said.After what Masimo thought were productive meetings, Apple instead hired O’Reilly, who was then Masimo’s chief medical officer and was “privy to extremely sensitive information,” according to the suit.The next year, it hired Marcelo Lamego, who was Cercacor’s chief technology officer and a former Masimo scientist. Lamego had “unfettered access” to confidential technical information and, shortly after starting work at Apple, began pursuing patent applications for things that he learned at the companies. Apple knew it was getting confidential information from the two men, the companies said.“Given what appeared to be a targeted effort to obtain information and expertise from Masimo and Cercacor, Masimo and Cercacor warned Apple about respecting their rights,” the companies said in the complaint.Neither man was named as a defendant in the suit.Read more on another Watch lawsuitMasimo and Cercacor also are seeking to add their engineers to seven patents and applications that were issued to Lemego. That would make Masimo and Cercacor owners, or at least joint owners, of those patents and applications currently assigned to Apple.It’s not the first time that Apple’s faced allegations of strong-arming information from companies that thought they were working with the tech giant. In October, it was accused of stealing patented technology from an email developer and then removing the man’s messaging service from its App Store so it wouldn’t be a competitor.Apple has also been accused of incorporating another’s patented invention into its Watch without paying. Last month, a New York cardiologist filed a lawsuit saying Apple owes him royalties on the Watch feature that provides notifications of an irregular heartbeat.The case is Masimo Corp. v. Apple Inc., 20-48, U.S. District Court for the Central District of California (Santa Ana).(Updates with O’Reilly in second paragraph.)To contact the reporters on this story: Susan Decker in Washington at sdecker1@bloomberg.net;Mark Gurman in Los Angeles at mgurman1@bloomberg.netTo contact the editors responsible for this story: Jon Morgan at jmorgan97@bloomberg.net, Joe SchneiderFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod
    Zacks

    Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod

    Masimo (MASI) will cater to the whole prenatal patient population, with the recent FDA clearance within the SET pulse oximetry business.

  • Here's Why You Should Hold on to Masimo (MASI) Stock Now
    Zacks

    Here's Why You Should Hold on to Masimo (MASI) Stock Now

    Masimo (MASI) raises revenue and earnings guidance for 2019.

  • Masimo (MASI) Expands Partnership with Texas-Based Drager
    Zacks

    Masimo (MASI) Expands Partnership with Texas-Based Drager

    Masimo (MASI) sees a slew of developments in recent times.

  • Did Masimo Corporation's (NASDAQ:MASI) Recent Earnings Growth Beat The Trend?
    Simply Wall St.

    Did Masimo Corporation's (NASDAQ:MASI) Recent Earnings Growth Beat The Trend?

    In this article, I will take a look at Masimo Corporation's (NasdaqGS:MASI) most recent earnings update (28 September...

  • Do Hedge Funds Love Masimo Corporation (MASI)?
    Insider Monkey

    Do Hedge Funds Love Masimo Corporation (MASI)?

    We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]

  • TEST Business Wire Releases

    Masimo to Present at Piper Jaffray 31st Annual Healthcare Conference

    Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Piper Jaffray 31st Annual Healthcare Conference at the Lotte New York Palace Hotel on Wednesday, December 4, 2019 at 9:30 a.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.

  • Digital Health Gaining Momentum: 3 MedTech Stocks in Focus
    Zacks

    Digital Health Gaining Momentum: 3 MedTech Stocks in Focus

    Digital health is committed to changing the face of healthcare as evident from its innovative solutions for the betterment of patients' lives.

  • Should You Be Impressed By Masimo Corporation's (NASDAQ:MASI) ROE?
    Simply Wall St.

    Should You Be Impressed By Masimo Corporation's (NASDAQ:MASI) ROE?

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

  • Thomson Reuters StreetEvents

    Edited Transcript of MASI earnings conference call or presentation 30-Oct-19 8:30pm GMT

    Q3 2019 Masimo Corp Earnings Call

  • Masimo (MASI) Earnings Beat Estimates in Q3, View Raised
    Zacks

    Masimo (MASI) Earnings Beat Estimates in Q3, View Raised

    Masimo (MASI) raises its 2019 product revenue guidance.

  • Masimo (MASI) Surpasses Q3 Earnings and Revenue Estimates
    Zacks

    Masimo (MASI) Surpasses Q3 Earnings and Revenue Estimates

    Masimo (MASI) delivered earnings and revenue surprises of 7.04% and 3.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Medical Products' Oct 30 Earnings Roster: MCK, MASI & More
    Zacks

    Medical Products' Oct 30 Earnings Roster: MCK, MASI & More

    Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have driven the performance of the players in the medical products space this earnings season.

  • Masimo (MASI) Reports Next Week: What You Should Expect
    Zacks

    Masimo (MASI) Reports Next Week: What You Should Expect

    Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Masimo Corporation (NASDAQ:MASI) Is Employing Capital Very Effectively
    Simply Wall St.

    Masimo Corporation (NASDAQ:MASI) Is Employing Capital Very Effectively

    Today we'll evaluate Masimo Corporation (NASDAQ:MASI) to determine whether it could have potential as an investment...

  • Were Hedge Funds Right About Souring On Masimo Corporation (MASI)?
    Insider Monkey

    Were Hedge Funds Right About Souring On Masimo Corporation (MASI)?

    We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of June 28th. In this article, we look at what those funds think of Masimo Corporation (NASDAQ:MASI) based on that data. […]

  • 5 Health Care Stocks Held By Gurus
    GuruFocus.com

    5 Health Care Stocks Held By Gurus

    Bausch Health Companies tops the list Continue reading...

  • Here's Why You Should Retain HMS Holdings (HMSY) Stock For Now
    Zacks

    Here's Why You Should Retain HMS Holdings (HMSY) Stock For Now

    HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services as well as robust margins despite intense competition.

  • Have Insiders Been Selling Masimo Corporation (NASDAQ:MASI) Shares?
    Simply Wall St.

    Have Insiders Been Selling Masimo Corporation (NASDAQ:MASI) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...